Sharon Bio-Medicine reports standalone net loss of Rs 179.38 crore in the June 2016 quarter

Sales decline 73.35% to Rs 37.83 crore

Net Loss of Sharon Bio-Medicine reported to Rs 179.38 crore in the quarter ended June 2016 as against net loss of Rs 82.43 crore during the previous quarter ended June 2015. Sales declined 73.35% to Rs 37.83 crore in the quarter ended June 2016 as against Rs 141.96 crore during the previous quarter ended June 2015. ParticularsQuarter EndedJun. 2016Jun. 2015% Var.Sales37.83141.96 -73 OPM %-365.503.71 -PBDT-151.36-43.30 -250 PBT-156.39-48.84 -220 NP-179.38-82.43 -118

Powered by Capital Market - Live News